Evidence map›Paper›PMID 37961320›Full record

ArticlebioRxiv : the preprint server for biology2023

Micrococcin cysteine-to-thiazole conversion through transient interactions between a scaffolding protein and two modification enzymes.

Diana G Calvopina-Chavez, Devan M Bursey, Yi-Jie Tseng, Leena M Patil, Kathryn D Bewley, Philip R Bennallack, Josh M McPhie, Kimberly B Wagstaff, Anisha Daley, Susan M Miller and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Diana G Calvopina-ChavezDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602.
Devan M BurseyDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602.
Yi-Jie TsengDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.
Leena M PatilDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.
Kathryn D BewleyDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143.
Philip R BennallackDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602.
Josh M McPhieDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.
Kimberly B WagstaffDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.
Anisha DaleyDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.
Susan M MillerDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143.
James D MoodyDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.ORCID 0000-0003-2266-5348
John C PriceDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602.
Joel S GriffittsDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602.

Funding

Biochemical Consequences of Regiospecific Metabolic Bias in the BrainR01AG066874 · NIA · BRIGHAM YOUNG UNIVERSITY · PI PRICE, JOHN C. · 2020 to 2024
$3.0M
The structural basis of spatially constrained enzymatic promiscuityR15GM132852 · NIGMS · BRIGHAM YOUNG UNIVERSITY · PI GRIFFITTS, JOEL S · 2019 to 2019
$338k
NIA NIH HHS R01 AG066874NIGMS NIH HHS R15 GM132852
6 · The paper itself

Abstract

Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a broad group of compounds mediating microbial competition in nature. Azole/azoline heterocycle formation in the peptide backbone is a key step in the biosynthesis of many RiPPs. Heterocycle formation in RiPP precursors is often carried out by a scaffold protein, an ATP-dependent cyclodehydratase, and an FMN-dependent dehydrogenase. It has generally been assumed that the orchestration of these modifications is carried out by a stable complex including the scaffold, cyclodehydratase and dehydrogenase. The antimicrobial RiPP micrococcin begins as a precursor peptide (TclE) with a 35-amino acid N-terminal leader and a 14-amino acid C-terminal core containing six Cys residues that are converted to thiazoles. The putative scaffold protein (TclI) presumably presents the TclE substrate to a cyclodehydratase (TclJ) and a dehydrogenase (TclN) to accomplish the two-step installation of the six thiazoles. In this study, we identify a minimal TclE leader region required for thiazole formation, we demonstrate complex formation between TclI, TclJ and TclN, and further define regions of these proteins required for complex formation. Our results point to a mechanism of thiazole installation in which TclI associates with the two enzymes in a mutually exclusive fashion, such that each enzyme competes for access to the peptide substrate in a dynamic equilibrium, thus ensuring complete modification of each Cys residue in the TclE core.

Indexed as

post-translationally modified peptidesthiazolethiopeptide

Identifiers

PMID37961320
PMCPMC10634744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.